Belimumab is not associated with COVID-19 mRNA vaccination failure in systemic lupus erythematosus

Rheumatology (Oxford). 2023 Mar 1;62(3):e34-e35. doi: 10.1093/rheumatology/keac459.
No abstract available

MeSH terms

  • COVID-19*
  • Humans
  • Immunosuppressive Agents
  • Lupus Erythematosus, Systemic*
  • RNA, Messenger
  • Treatment Outcome
  • Vaccination

Substances

  • belimumab
  • Immunosuppressive Agents
  • RNA, Messenger